Oct 1(Reuters) - The European health regulator said on Thursday it started a rolling review of the experimental COVID-19 vaccine from AstraZeneca and Oxford University, aiming to speed up any future approval process.
The European Medicines Agency (EMA) said its human medicines committee has started evaluating the first batch of data on the vaccine, and will continue till sufficient data is available and a formal application is submitted. (bit.ly/36qyDZM)
The news comes just weeks after several global trials of the vaccine were halted due to an unexplained illness in a study participant. U.S. trials are still under review, with regulators widening their probe. (Reporting by Pushkala Aripaka in Bengaluru; editing by Patrick Graham and Shinjini Ganguli)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.